ArticleMolecular medicine reports2019
The role and mechanism of microRNA‑18a‑5p in oral squamous cell carcinoma.
Article in Molecular medicine reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- MicroRNA mediated signaling and metabolic reprogramming in oral squamous cell carcinoma.Medical oncology (Northwood, London, England) · 2026Review
- TGF-β Signaling in Progression of Oral Cancer.International journal of molecular sciences · 2023Review
- Research progress and clinical application prospects of miRNAs in oral cancer.Molecular biology reports · 2022Review
- MicroRNA-18a regulates the metastatic properties of oral squamous cell carcinoma cells via HIF-1α expression.BMC oral health · 2022Article
- Non-Coding RNAs and Oral Cancer: Small Molecules With Big Functions.Frontiers in oncology · 2022Review
- MicroRNAs as Modulators of Oral Tumorigenesis-A Focused Review.International journal of molecular sciences · 2021Review
- Immunohistochemical Expression of Epithelial Mesenchymal Transition Proteins in Squamous Cell Carcinoma of the Oral Cavity.Iranian journal of pathology · 2021Article
- miR-371b-5p promotes cell proliferation, migration and invasion in non-small cell lung cancer via SCAI.Bioscience reports · 2020Article
- MicroRNA-18a-5p Suppresses Tumor GrowthFrontiers in oncology · 2020Article
- Relevance of micro-RNAs and their targets as a diagnostic and prognostic marker in oral squamous cell carcinoma.Journal of oral and maxillofacial pathology : JOMFPReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The purpose of this study was mainly to explore the role and mechanism of microRNA‑18a‑5p (miR‑18a‑5p) in oral squamous cell carcinoma (OSCC). The expression of miR‑18a‑5p in OSCC cells and normal cells was firstly detected using reverse transcription‑quantitative polymerase chain reaction (RT‑qPCR). The cell viability, apoptosis, migration and invasion abilities of OSCC cells were determined by MTT, cell apoptosis, wound healing and Transwell assays respectively. Additionally, bioinformatics software analysis and luciferase reporter assays were performed to predict and confirm the candidate target of miR‑18a‑5p. Western blot analysis was used to assess protein expression. It was revealed that the expression of miR‑18a‑5p in OSCC cells was higher than that in normal cells. In vitro studies revealed that the cell viability, migration and invasion abilities of OSCC cells were promoted and cell apoptosis was inhibited by miR‑18a‑5p overexpression. In addition, Smad2 was identified as a target of miR‑18a‑5p. It was also revealed that miR‑18a‑5p overexpression significantly inhibited the expression of Smad2, Smad4 and E‑cadherin, and the levels of Smad7, collagen I, transforming growth factor‑β (TGF‑β), α‑smooth muscle actin (α‑SMA), vimentin were enhanced. While miR‑18a‑5p downregulation presented the opposite effects. In conclusion, the results indicated that miR‑18a‑5p can regulate the biological process of OSCC by targeting Smad2 and miR‑18a‑5p/Smad2 may be potential therapeutic targets for OSCC.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.